Younghoon Kwon1, Ryan J Koene2, Osung Kwon2, Jessica V Kealhofer2, Selcuk Adabag2, Sue Duval2. 1. From the Cardiovascular Division, Department of Medicine, University of Virginia, Charlottesville (Y.K.); Cardiovascular Division, University of Minnesota Medical School, Minneapolis (R.J.K., J.V.K., S.D.); Department of Internal Medicine, Asan Medical Center, Ulsan Medical College, Seoul, Korea (O.K.); and Cardiovascular Division, Minneapolis VA Healthcare System, MN (S.A.). yk2j@hscmail.mcc.virginia.edu. 2. From the Cardiovascular Division, Department of Medicine, University of Virginia, Charlottesville (Y.K.); Cardiovascular Division, University of Minnesota Medical School, Minneapolis (R.J.K., J.V.K., S.D.); Department of Internal Medicine, Asan Medical Center, Ulsan Medical College, Seoul, Korea (O.K.); and Cardiovascular Division, Minneapolis VA Healthcare System, MN (S.A.).
Abstract
BACKGROUND: Patients with heart failure and reduced ejection fraction are at increased risk of malignant ventricular arrhythmias. Implantable cardioverter-defibrillator (ICD) is recommended to prevent sudden cardiac death in some of these patients. Sleep-disordered breathing (SDB) is highly prevalent in this population and may impact arrhythmogenicity. We performed a systematic review and meta-analysis of prospective studies that assessed the impact of SDB on ICD therapy. METHODS AND RESULTS: Relevant prospective studies were identified in the Ovid MEDLINE, EMBASE, and Google Scholar databases. Weighted risk ratios of the association between SDB and appropriate ICD therapies were estimated using random effects meta-analysis. Nine prospective cohort studies (n=1274) were included in this analysis. SDB was present in 52% of the participants. SDB was associated with a 55% higher risk of appropriate ICD therapies (45% versus 28%; risk ratio, 1.55; 95% confidence interval, 1.32-1.83). In a subgroup analysis based on the subtypes of SDB, the risk was higher in both central (risk ratio, 1.50; 95% confidence interval, 1.11-2.02) and obstructive (risk ratio, 1.43; 95% confidence interval, 1.01-2.03) sleep apnea. CONCLUSIONS: SDB is associated with an increased risk of appropriate ICD therapy in patients with heart failure and reduced ejection fraction.
BACKGROUND:Patients with heart failure and reduced ejection fraction are at increased risk of malignant ventricular arrhythmias. Implantable cardioverter-defibrillator (ICD) is recommended to prevent sudden cardiac death in some of these patients. Sleep-disordered breathing (SDB) is highly prevalent in this population and may impact arrhythmogenicity. We performed a systematic review and meta-analysis of prospective studies that assessed the impact of SDB on ICD therapy. METHODS AND RESULTS: Relevant prospective studies were identified in the Ovid MEDLINE, EMBASE, and Google Scholar databases. Weighted risk ratios of the association between SDB and appropriate ICD therapies were estimated using random effects meta-analysis. Nine prospective cohort studies (n=1274) were included in this analysis. SDB was present in 52% of the participants. SDB was associated with a 55% higher risk of appropriate ICD therapies (45% versus 28%; risk ratio, 1.55; 95% confidence interval, 1.32-1.83). In a subgroup analysis based on the subtypes of SDB, the risk was higher in both central (risk ratio, 1.50; 95% confidence interval, 1.11-2.02) and obstructive (risk ratio, 1.43; 95% confidence interval, 1.01-2.03) sleep apnea. CONCLUSIONS: SDB is associated with an increased risk of appropriate ICD therapy in patients with heart failure and reduced ejection fraction.
Authors: P A Lanfranchi; A Braghiroli; E Bosimini; G Mazzuero; R Colombo; C F Donner; P Giannuzzi Journal: Circulation Date: 1999-03-23 Impact factor: 29.690
Authors: Hanqiao Wang; John D Parker; Gary E Newton; John S Floras; Susanna Mak; Kuo-Liang Chiu; Pimon Ruttanaumpawan; George Tomlinson; T Douglas Bradley Journal: J Am Coll Cardiol Date: 2007-04-02 Impact factor: 24.094
Authors: S J Connolly; M Gent; R S Roberts; P Dorian; D Roy; R S Sheldon; L B Mitchell; M S Green; G J Klein; B O'Brien Journal: Circulation Date: 2000-03-21 Impact factor: 29.690
Authors: S Javaheri; T J Parker; J D Liming; W S Corbett; H Nishiyama; L Wexler; G A Roselle Journal: Circulation Date: 1998-06-02 Impact factor: 29.690
Authors: Thomas Bitter; Klaus-Jürgen Gutleben; Georg Nölker; Nina Westerheide; Christian Prinz; Zisis Dimitriadis; Dieter Horstkotte; Jürgen Vogt; Olaf Oldenburg Journal: J Cardiovasc Electrophysiol Date: 2013-07-11
Authors: Michael Dong; Linda Liu; Kenneth C Bilchick; Nishaki K Mehta; Yoon-Sik Cho; Ryan J Koene; Selcuk Adabag; Adrian Baranchuk; Neal A Chatterjee; T Jared Bunch; Hirad Yarmohammadi; Younghoon Kwon Journal: Sleep Breath Date: 2022-06-01 Impact factor: 2.816
Authors: Patrick L Stafford; Evan K Harmon; Paras Patel; McCall Walker; Gen-Min Lin; Seung-Jung Park; Neal A Chatterjee; Nishaki K Mehta; Sula Mazimba; Kenneth Bilchick; Younghoon Kwon Journal: Sleep Med Res Date: 2021-06-24
Authors: Christian M Horvath; Christoph Fisser; T Douglas Bradley; John S Floras; Samuel Sossalla; Gianfranco Parati; Florian Zeman; Paolo Castiglioni; Andrea Faini; Fiona Rankin; Michael Arzt Journal: Int J Cardiol Heart Vasc Date: 2022-05-21
Authors: Younghoon Kwon; Jeffrey R Misialek; Daniel Duprez; David R Jacobs; Alvaro Alonso; Susan R Heckbert; Ying Y Zhao; Susan Redline; Elsayed Z Soliman Journal: Ann Noninvasive Electrocardiol Date: 2018-07-02 Impact factor: 1.468
Authors: M Habibović; L Mudde; S S Pedersen; D Schoormans; J Widdershoven; J Denollet Journal: Eur J Cardiovasc Nurs Date: 2017-12-20 Impact factor: 3.908
Authors: McCall Walker; Jacob N Blackwell; Patrick Stafford; Paras Patel; Sula Mazimba; Nishaki Mehta; Yeilim Cho; Michael Mangrum; Saman Nazarian; Kenneth Bilchick; Younghoon Kwon Journal: Sleep Disord Date: 2020-02-05